1. Home
  2. ATCH vs LTRN Comparison

ATCH vs LTRN Comparison

Compare ATCH & LTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AtlasClear Holdings Inc.

ATCH

AtlasClear Holdings Inc.

N/A

Current Price

$0.18

Market Cap

29.6M

Sector

N/A

ML Signal

N/A

Logo Lantern Pharma Inc.

LTRN

Lantern Pharma Inc.

N/A

Current Price

$1.11

Market Cap

27.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ATCH
LTRN
Founded
2022
2013
Country
United States
United States
Employees
46
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
29.6M
27.6M
IPO Year
2024
2020

Fundamental Metrics

Financial Performance
Metric
ATCH
LTRN
Price
$0.18
$1.11
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
★ $1.00
N/A
AVG Volume (30 Days)
★ 3.8M
233.7K
Earning Date
05-15-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 18.65
EPS
★ 0.02
N/A
Revenue
★ $20,052,635.00
N/A
Revenue This Year
$84.47
N/A
Revenue Next Year
$39.32
N/A
P/E Ratio
$9.14
★ N/A
Revenue Growth
★ 84.70
N/A
52 Week Low
$0.17
$1.08
52 Week High
$0.61
$4.70

Technical Indicators

Market Signals
Indicator
ATCH
LTRN
Relative Strength Index (RSI) 44.26 20.81
Support Level $0.18 $1.11
Resistance Level $0.22 $1.96
Average True Range (ATR) 0.02 0.16
MACD 0.00 -0.03
Stochastic Oscillator 19.33 3.53

Price Performance

Historical Comparison
ATCH
LTRN

About ATCH AtlasClear Holdings Inc.

AtlasClear Holdings Inc is a fintech company. Its goal is to build a cutting-edge technology-enabled financial services firm that would create a more efficient platform for trading, clearing, settlement, and banking of evolving and financial products with a focus on financial services firms. It is a fintech-driven business-to-business platform that expects to power innovation in fintech, investing, and trading. The company believes it is positioned to provide a modern, mission-critical suite of solutions to its clients, enabling them to reduce their transaction costs and compete more effectively in their businesses.

About LTRN Lantern Pharma Inc.

Lantern Pharma Inc is a biopharmaceutical company focused on developing oncology drug candidates using its artificial intelligence platform. The company utilizes its proprietary RADR platform to identify, develop, and advance small molecule therapies and antibody-drug conjugates, with a pipeline that includes three lead small molecule drug candidates (LP-300, LP-184, and LP-284) targeting solid tumors and blood cancers. It also advances programs through its subsidiary focused on central nervous system and brain cancers.

Share on Social Networks: